News Abbott Laboratories Swiss Exchange

Stocks

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Delayed Swiss Exchange 23:36:16 18/09/2026 HKT			5-day change	1st Jan Change
84.50 ^CHF	+1.20%		+0.60%	-14.65%

09-22	Grail rallies as FDA staff flags no major concerns for multi-cancer test	RE
09-19	Trinity Heart Experts First in the Quad Cities to Use New Afib Technology	CI

All News

Mentions Relevance

09-19	Trinity Heart Experts First in the Quad Cities to Use New Afib Technology	CI
09-18	Abbott Laboratories Declares Quarterly Dividend, Payable on Nov. 16, 2026	CI
09-18	Abbott Laboratories Keeps Quarterly Dividend at $0.63 a Share, Payable Nov. 16 to Holders of Record on Oct. 15	MT
09-18	Abbott declares 411th consecutive quarterly dividend	PR
09-15	Abbott Announces First Canadian Use of Volt Pulsed Field Ablation System to Treat Atrial Fibrillation	CI
09-15	First Canadian Commercial Use of Abbott's Volt™ Pulsed Field Ablation System Advances Minimally Invasive Atrial Fibrillation Care	AQ
09-15	Abbott to pay $385M over infant formula contamination probe	AQ
09-15	Abbott agrees to settlement over closure of largest baby formula plant in the US	AQ
09-15	Abbott Laboratories to Pay $385 Million to Settle Infant Formula Allegations	MT
09-15	Abbott to Pay $385 Million to Resolve Baby Formula Contamination Claims	DJ
09-14	Abbott to pay $384 million over contaminated infant formula allegations, US Justice Dept says	RE
09-14	Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recall	PR
09-08	Abbott Receives FDA Approval for Device to Treat Abnormal Heart Rhythm	DJ
09-08	Abbott Receives FDA Approval for TactiFlex Duo Ablation Catheter to Treat Abnormal Heart Rhythms	CI
09-08	Abbott Laboratories Wins FDA Approval for Dual-Energy AFib Catheter	MT
09-08	The FDA Clears an Abbott Product
09-01	Colorectal Cancer Alliance and Abbott Launch Online Hub Explaining Unexpected Home Delivery Of Colorectal Cancer Screening Kits	CI
08-31	Abbott Launches Similac 360 Total Care Made with Whole Milk Ready-To-Feed Liquid Infant Formula in the United States	CI
08-31	Abbott Laboratories : Late-breaking data for Abbott’s TactiFlex™ Duo Ablation Catheter reveal positive outcomes for treating complex AFib cases	PU
08-31	Abbott Laboratories Introduces Similac 360 Total Care Made With Whole Milk in US	MT
08-31	Abbott launches the first and only ready-to-feed liquid infant formula made with whole milk in the U.S. at similar price to its existing Similac powdered formula	PR
08-31	Abbott Presents Positive 12-Month Outcomes for Tactiflex Duo Ablation Catheter in Treating Complex Afib Cases	CI
08-28	Abbott Laboratories Insider Sold Shares Worth $46,204,798, According to a Recent SEC Filing	MT
08-27	Abbott Laboratories' Stroke Treatment Device Receives CE Mark	MT
08-27	Abbott's next-generation Amulet 360™ device receives CE Mark to treat people with atrial fibrillation at risk of stroke	PR